NCT02674529View on ClinicalTrials.gov

Study of Neural Responses Induced by Antidepressant Effects

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Major Depressive Disorder
Interventions
DRUG

Escitalopram

Selective Serotonin Reuptake Inhibitor (SSRI)

DRUG

Placebo

Placebo

BEHAVIORAL

Real-time Neurofeedback fMRI task pre- and post-RCT

Placebo experiment during an fMRI scanning session

Trial Locations (1)

15213

WPIC, Pittsburgh

All Listed Sponsors
lead

Marta Peciña, MD PhD

OTHER

NCT02674529 - Study of Neural Responses Induced by Antidepressant Effects | Biotech Hunter | Biotech Hunter